Subgroup | Meta-analysis | Â | Heterogeneity | Effect model | ||||
---|---|---|---|---|---|---|---|---|
Number of included studies ( n) | Number of patients ( n) | Cases of SO( n) | Prevalence (95% Cl) | Â | P | I2 (%) | ||
Diagnostic criteria of sarcopenia | Â | Â | Â | Â | Â | Â | Â | Â |
Low muscle mass | 14 | 32,213 | 8265 | 21%(13%, 29%) |  | P < 0.01 | 99.5% | Random |
Low muscle strength | 10 | 19,096 | 2691 | 12%(8%, 16%) |  | P < 0.01 | 98% | Random |
Low muscle mass + Low muscle strength | 20 | 20,169 | 2039 | 10%(6%, 14%) |  | P < 0.01 | 98% | Random |
Diagnostic criteria of SO | Â | Â | Â | Â | Â | Â | Â | Â |
Low muscle mass + BMI | 2 | 7311 | 1312 | 18%(9%, 29%) |  | P < 0.01 | 99% | Random |
Low muscle mass + PBF% | 5 | 10,760 | 4700 | 29%(13%, 49%) |  | P < 0.01 | 98% | Random |
Low muscle mass + WC | 5 | 13,056 | 2096 | 18%(7%, 32%) |  | P < 0.01 | 98% | Random |
Low muscle strength + BMI | 5 | 4397 | 584 | 11%(5%, 19%) |  | P < 0.01 | 98% | Random |
Low muscle strength + PBF% | 2 | 1308 | 87 | 8%(2%, 19%) |  | P < 0.01 | 96% | Random |
Low muscle mass + Low muscle strength + PBF% | 9 | 11,191 | 1027 | 10%(6%, 14%) |  | P < 0.01 | 98% | Random |
Low muscle mass + Low muscle strength + BMI | 4 | 4071 | 679 | 18%(15%, 20%) |  | P = 0.07 | 57% | Random |
Low muscle mass + Low muscle strength + BMI + WC + PBF% | 3 | 2005 | 144 | 9%(3%, 17%) |  | P < 0.01 | 94% | Random |
Study design | Â | Â | Â | Â | Â | Â | Â | Â |
Cohort study | 17 | 30,836 | 3742 | 13%(9%, 17%) |  | P < 0.01 | 99% | Random |
Cross-sectional study | 29 | 40,921 | 5523 | 13%(10%, 16%) |  | P < 0.01 | 99% | Random |
Geographical region | Â | Â | Â | Â | Â | Â | Â | Â |
Asia | 22 | 43,722 | 6109 | 12%(9%, 16%) |  | P < 0.01 | 99% | Random |
Europe | 10 | 7930 | 989 | 11%(7%, 15%) |  | P < 0.01 | 97% | Random |
Eurasian | 2 | 1180 | 187 | 14%(3%, 31%) |  | P < 0.01 | 98% | Random |
South America | 6 | 954 | 224 | 22%(12%, 35%) |  | P < 0.01 | 90% | Random |
North America | 2 | 7422 | 1068 | 16%(10%, 24%) |  | P < 0.01 | 98% | Random |
Oceania | 2 | 2647 | 216 | 8%(5%, 11%) |  | P < 0.01 | 88% | Random |
Age | Â | Â | Â | Â | Â | Â | Â | Â |
65–74 | 9 | 12,860 | 1700 | 13%(9%, 18%) |  | P < 0.01 | 98% | Random |
75–84 | 7 | 5597 | 1006 | 17%(11%, 25%) |  | P < 0.01 | 97% | Random |
≥ 85 | 4 | 1166 | 162 | 23%(11%, 37%) |  | P < 0.01 | 92% | Random |
Gender | Â | Â | Â | Â | Â | Â | Â | Â |
Female | 38 | 34,477 | 7072 | 15%(11%, 19%) |  | P < 0.01 | 99.2% | Random |
Male | 34 | 28,414 | 4506 | 13%(10%, 17%) |  | P < 0.01 | 99% | Random |
Race | Â | Â | Â | Â | Â | Â | Â | Â |
White | 3 | 4494 | 586 | 23%(10%, 38%) |  | P < 0.01 | 97% | Random |
Black | 4 | 1519 | 233 | 17%(12%, 23%) |  | P = 0.02 | 71% | Random |
Education level | Â | Â | Â | Â | Â | Â | Â | Â |
< High school | 7 | 14,398 | 3100 | 16%(9%, 24%) |  | P < 0.01 | 99% | Random |
High school to some college | 6 | 6191 | 923 | 14%(6%, 245) |  | P < 0.01 | 98% | Random |
College or more | 8 | 4031 | 446 | 11%(5%, 19%) |  | P < 0.01 | 96% | Random |
Physical activity | Â | Â | Â | Â | Â | Â | Â | Â |
Moderate physical activity | 13 | 14,450 | 3599 | 15%(8%, 23%) |  | P < 0.01 | 99.5% | Random |
Vigorous physical activity | 4 | 1362 | 173 | 12%(4%, 23%) |  | P < 0.01 | 98% | Random |
Not very/not at all | 7 | 7904 | 1908 | 17%(8%, 29%) |  | P < 0.01 | 99.5% | Random |
Fall history | Â | Â | Â | Â | Â | Â | Â | Â |
Yes | 5 | 867 | 136 | 15%(10%, 22%) |  | P < 0.01 | 82% | Random |
No | 5 | 5159 | 547 | 9%(4%, 14%) |  | P < 0.01 | 98% | Random |
Number of chronic diseases | Â | Â | Â | Â | Â | Â | Â | Â |
0 | 3 | 6794 | 1493 | 16%(3%, 37%) |  | P < 0.01 | 99.5% | Random |
1 | 4 | 5784 | 431 | 10%(2%, 23%) |  | P < 0.01 | 99% | Random |
≥ 2 | 4 | 2549 | 548 | 19%(10%, 29%) |  | P < 0.01 | 97% | Random |
Comorbidities | Â | Â | Â | Â | Â | Â | Â | Â |
Cancer | 2 | 1762 | 200 | 8%(2%, 18%) |  | P < 0.01 | 95% | Random |
Lung disease | 5 | 1878 | 354 | 16%(9%, 25%) |  | P < 0.01 | 85% | Random |
Hypertension | 10 | 10,356 | 1349 | 12%(8%, 17%) |  | P < 0.01 | 98% | Random |
Dyslipidemia | 6 | 4140 | 758 | 15%(6%, 27%) |  | P < 0.01 | 99% | Random |
Functional disabilities | 2 | 675 | 239 | 33%(29%, 37%) |  | P = 0.95 | 0% | Fixed |
Osteoporosis | 4 | 1892 | 488 | 20%(8%, 35%) |  | P < 0.01 | 96% | Random |
Arthritis | 6 | 5334 | 1027 | 17%(10%, 25%) |  | P < 0.01 | 95% | Random |
Probable Dementia | 2 | 72 | 29 | 35%(9%,65%) |  | P = 0.02 | 83% | Random |
Cerebrovascular disease | 5 | 820 | 106 | 9%(5%, 14%) |  | P < 0.01 | 71% | Random |
Diabetes | 14 | 4497 | 825 | 14%(10%, 19%) |  | P < 0.01 | 95% | Random |
Heart disease | 10 | 3523 | 592 | 14%(9%, 19%) |  | P < 0.01 | 92% | Random |
Depressive Symptoms | 4 | 837 | 168 | 16%(7%, 28%) |  | P < 0.01 | 96% | Random |
High fasting glucose | Â | Â | Â | Â | Â | Â | Â | Â |
Yes | 2 | 1207 | 105 | 17%(1%, 49%) |  | P < 0.01 | 98% | Random |
No | 2 | 1754 | 89 | 12%(1%, 42%) |  | P < 0.01 | 98% | Random |
Drug use | Â | Â | Â | Â | Â | Â | Â | Â |
Oral hypoglycemic agents | 2 | 392 | 46 | 11%(6%, 17%) |  | P = 0.09 | 66% | Random |
Use of anti-psychotics | 2 | 30 | 4 | 13%(2%, 28%) |  | P = 0.32 | 0% | Fixed |
Statin use | 3 | 1028 | 60 | 6%(4%, 7%) |  | P = 0.53 | 0% | Fixed |